These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3373705)

  • 21. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension.
    Horio T; Miyazato J; Kamide K; Takiuchi S; Kawano Y
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):938-44. PubMed ID: 14573332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lipid and lipoprotein levels of middle-aged and elderly Chinese men and women in Shandong Province.
    Wang M; Hou X; Hu W; Chen L; Chen S
    Lipids Health Dis; 2019 Mar; 18(1):58. PubMed ID: 30832658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
    Bhavani AB; Sastry KB; Reddy NK; Padma T
    Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
    Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
    Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood lipid changes in hypertensive, dyslipidemic patients under long term quinapril treatment.
    Cangelosi MM; Gaudio M; Brancati AM; Leggio F
    Int Angiol; 1994 Mar; 13(1):65-7. PubMed ID: 8077801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].
    Lu HH; Li Q; Xu BH; Zhang P; Yuan P; Wang JY; Cai RG
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):520-5. PubMed ID: 22093630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994.
    Rafiei M; Boshtam M; Sarraf-Zadegan N
    East Mediterr Health J; 1999 Jul; 5(4):766-77. PubMed ID: 11338699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension].
    Liu A; Li L; Cao W; Shan S; Lu J; Guo X; Hu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):151-7. PubMed ID: 15793775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
    Hopkins PN; Wu LL; Hunt SC; Brinton EA
    J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The child as proband. High prevalence of unrecognized and untreated hyperlipidemia in parents of hyperlipidemic children.
    Gidding SS; Whiteside P; Weaver S; Bookstein L; Rosenbaum D; Christoffel K
    Clin Pediatr (Phila); 1989 Oct; 28(10):462-5. PubMed ID: 2791435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
    Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
    Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.